Sign Out
There is conclusive information as to whether doxorubicin may adversely affect human fertility or cause teratogenesis.
Experimental data, however, suggest that doxorubicin may harm the foetus and should, therefore, not be administered to pregnant women or to mothers who are breast feeding.
